Navigation Links
Pharmasset to Present at the Rodman & Renshaw Healthcare Conference on Tuesday, May 20th
Date:5/13/2008

idates. Clevudine, for the treatment of chronic HBV infection, is enrolling Phase 3 clinical trials for registration in North, Central and South America and Europe. Clevudine is already approved for HBV in South Korea and marketed by Bukwang Pharmaceuticals in South Korea under the brand name Levovir. R7128, an oral treatment for chronic HCV infection, is in a 4-week Phase 1 clinical trial in combination with Pegasys(R) plus Copegus(R) through a strategic collaboration with Roche. Racivir, which is being developed for the treatment of HIV in combination with other approved HIV drugs, has completed a Phase 2 clinical trial.
Pegasys(R) and Copegus(R) are registered trademarks of Roche.

Contact

Alan Roemer, Vice President

Investor Relations & Corporate Communications

alan.roemer@pharmasset.com

Office: +1 (609) 613-4125


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Pharmassets Underwriters Release Shares from Lock-Up
2. Pharmasset Presents R7128 14-Day Monotherapy Study Results for the Treatment of Chronic Hepatitis C
3. Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales
4. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
5. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
6. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
7. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
8. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
9. AtriCure to Present at Roth Capital Partners 2007 New York Conference
10. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
11. MDS to Present at Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... (PRWEB) May 06, 2015 The Beryl ... 1 of Patient Experience Journal (PXJ), an international, ... practices around understanding and improving patient experience. The second ... patient experience conversation globally, helps align the voices engaged ... , Published in association with The Beryl Institute, ...
(Date:5/6/2015)... “ SideChef ” was featured on NewsWatch as ... latest and coolest applications on the market for iOS, Android, and ... the app review and shared with viewers how this application walks ... to be a good navigator people had to know how to ... is a master navigator. Well what if people could “GPS” their ...
(Date:5/6/2015)... Inversion Studios, a full-service training ... Pilates classes, provides personalized individual instruction and now ... its new Pilates Ring magic circle. , Inversion ... stronger, more centered and graceful, Inversion Studios and ... to healthy fitness through yoga and Pilates. With ...
(Date:5/6/2015)... 06, 2015 Vancouver Chiropractic Clinic, ... their new blog containing the Canadian Physical Activity ... Canadian Society for Exercise Physiology (CSEP). Since the ... health and fitness research and personal training in ... are highly beneficial and a rich resource for ...
(Date:5/6/2015)... Anitoa Systems, (“Anitoa”), a Palo Alto startup established ... successfully demonstrated a handheld real time quantitative-polymerase-chain-reaction system (qPCR) ... qPCR is shown to be capable of detecting several ... C, and E. Coli. This qPCR system has achieved ... 9 orders of magnitude dynamic range. A key ...
Breaking Medicine News(10 mins):Health News:Patient Experience Journal Releases Spring 2015 Issue 2Health News:An Application to Guide Users through Recipes Was Featured on NewsWatch Television 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:Vancouver Chiropractor Shares Canadian Physical Activity and Sedentary Behavior Guidelines by CSEP in New Blog 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... all been there: sitting,in the doctor,s waiting room for ... when a long wait is coupled with a hurried ... , "When doctors keep their ... combination of factors can be toxic," says patient satisfaction,expert ...
... Dictation technology within the NHS produces significant efficiency gains. , ... ... today announced that Sheffield Teaching Hospitals NHS Foundation Trust has implemented ... 5 hospitals on 2 campuses in one of the largest rollouts ...
... in an asthmatic,s exhaled breath can portend worsening ... attack linked to underlying airway inflammation. This has ... children, of significant interest as a potential way ... outcomes. However, a recent multi-center prospective study found ...
... has ignored their cost saving suggestionsHARRISBURG, Pa., Jan. 6 ... on closing the state,s budget shortfall, SEIU Local 668, ... across Pennsylvania, said they have identified millions of dollars ... should cancel contracts with private contractors for work that ...
... National Cholesterol Education Program tools, NCEP, do not accurately ... at the Yale University School of Medicine in New ... who had no history of coronary heart disease; although ... Lipitor) because of increased risk of developing coronary heart ...
... 6 Gen-Probe Incorporated (Nasdaq: GPRO ) announced ... J.P. Morgan Healthcare Conference on Wednesday, January 14, 2009 at ... is scheduled to be webcast live and may be accessed ... at www.gen-probe.com . The webcast will be available for ...
Cached Medicine News:Health News:DrScore.com Identifies 'Toxic Combination' 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 2Health News:Sheffield Teaching Hospitals NHS Foundation Trust delivers same day patient discharge via BigHand Digital Dictation 3Health News:NO help: Nitric oxide monitoring does not help most children with asthma 2Health News:NO help: Nitric oxide monitoring does not help most children with asthma 3Health News:State Human Services Union Identifies Ways to Save Millions of Tax Dollars 2Health News:Gen-Probe to Webcast Presentation at the 27th Annual J.P. Morgan Healthcare Conference 2
(Date:5/6/2015)... 2015 China Biologic Products, Inc. (NASDAQ: CBPO, ... plasma-based biopharmaceutical company in China, today announced its unaudited ... First Quarter 2015 Financial Highlights ... increased by 25.0% to $70.4 million from $56.3 million ... profit increased by 18.9% to $45.9 million from $38.6 ...
(Date:5/6/2015)... , May 6, 2015 Asterias ... company in the emerging field of regenerative medicine, ... meeting with the investment community to review the ... in spinal cord injury on Friday, May 8, ... clinical trial and future planned clinical activities for ...
(Date:5/6/2015)... Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) ... 31, 2015.  The net loss and the loss from ... $13.0 million, respectively, compared to $10.7 million and $8.8 ... March 31, 2015, Alexza had consolidated cash, cash equivalents, ... "We continue to focus on ways in which ...
Breaking Medicine Technology:China Biologic Reports Financial Results for the First Quarter of 2015 2China Biologic Reports Financial Results for the First Quarter of 2015 3China Biologic Reports Financial Results for the First Quarter of 2015 4China Biologic Reports Financial Results for the First Quarter of 2015 5China Biologic Reports Financial Results for the First Quarter of 2015 6China Biologic Reports Financial Results for the First Quarter of 2015 7China Biologic Reports Financial Results for the First Quarter of 2015 8China Biologic Reports Financial Results for the First Quarter of 2015 9China Biologic Reports Financial Results for the First Quarter of 2015 10China Biologic Reports Financial Results for the First Quarter of 2015 11China Biologic Reports Financial Results for the First Quarter of 2015 12China Biologic Reports Financial Results for the First Quarter of 2015 13China Biologic Reports Financial Results for the First Quarter of 2015 14China Biologic Reports Financial Results for the First Quarter of 2015 15China Biologic Reports Financial Results for the First Quarter of 2015 16China Biologic Reports Financial Results for the First Quarter of 2015 17China Biologic Reports Financial Results for the First Quarter of 2015 18Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Alexza Reports 2015 First Quarter Financial Results 2Alexza Reports 2015 First Quarter Financial Results 3Alexza Reports 2015 First Quarter Financial Results 4Alexza Reports 2015 First Quarter Financial Results 5Alexza Reports 2015 First Quarter Financial Results 6Alexza Reports 2015 First Quarter Financial Results 7Alexza Reports 2015 First Quarter Financial Results 8Alexza Reports 2015 First Quarter Financial Results 9Alexza Reports 2015 First Quarter Financial Results 10
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...
PremierEdge™ Tunnel Knives....
Medicine Products: